rs61741615

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_016507.4(CDK12):​c.3584C>T​(p.Thr1195Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0017 in 1,614,192 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T1195T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0093 ( 19 hom., cov: 32)
Exomes 𝑓: 0.00091 ( 22 hom. )

Consequence

CDK12
NM_016507.4 missense

Scores

5
13

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 0.790

Publications

6 publications found
Variant links:
Genes affected
CDK12 (HGNC:24224): (cyclin dependent kinase 12) Enables RNA polymerase II CTD heptapeptide repeat kinase activity and cyclin binding activity. Involved in phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; and regulation of MAP kinase activity. Located in nuclear speck. Part of cyclin K-CDK12 complex. [provided by Alliance of Genome Resources, Apr 2022]
CDK12 Gene-Disease associations (from GenCC):
  • Tourette syndrome
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002410978).
BP6
Variant 17-39526140-C-T is Benign according to our data. Variant chr17-39526140-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 133859.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00928 (1413/152302) while in subpopulation AFR AF = 0.0321 (1332/41552). AF 95% confidence interval is 0.0306. There are 19 homozygotes in GnomAd4. There are 697 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 19 Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDK12NM_016507.4 linkc.3584C>T p.Thr1195Met missense_variant Exon 13 of 14 ENST00000447079.6 NP_057591.2 Q9NYV4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDK12ENST00000447079.6 linkc.3584C>T p.Thr1195Met missense_variant Exon 13 of 14 1 NM_016507.4 ENSP00000398880.4 Q9NYV4-1
CDK12ENST00000430627.6 linkc.3584C>T p.Thr1195Met missense_variant Exon 13 of 14 1 ENSP00000407720.2 Q9NYV4-2
CDK12ENST00000584632.5 linkc.3581C>T p.Thr1194Met missense_variant Exon 13 of 13 5 ENSP00000464641.1 J3QSD7
CDK12ENST00000559663.2 linkn.3584C>T non_coding_transcript_exon_variant Exon 13 of 21 5 ENSP00000453329.2 H0YLT2

Frequencies

GnomAD3 genomes
AF:
0.00912
AC:
1388
AN:
152184
Hom.:
17
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0315
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00340
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00812
GnomAD2 exomes
AF:
0.00230
AC:
578
AN:
251316
AF XY:
0.00169
show subpopulations
Gnomad AFR exome
AF:
0.0322
Gnomad AMR exome
AF:
0.00104
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.000910
AC:
1330
AN:
1461890
Hom.:
22
Cov.:
32
AF XY:
0.000789
AC XY:
574
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.0321
AC:
1075
AN:
33480
American (AMR)
AF:
0.00172
AC:
77
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000325
AC:
28
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00173
AC:
10
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000117
AC:
13
AN:
1112012
Other (OTH)
AF:
0.00210
AC:
127
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
88
175
263
350
438
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00928
AC:
1413
AN:
152302
Hom.:
19
Cov.:
32
AF XY:
0.00936
AC XY:
697
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.0321
AC:
1332
AN:
41552
American (AMR)
AF:
0.00340
AC:
52
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000830
AC:
4
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68026
Other (OTH)
AF:
0.00803
AC:
17
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
67
135
202
270
337
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00356
Hom.:
19
Bravo
AF:
0.0108
ESP6500AA
AF:
0.0329
AC:
145
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00273
AC:
332
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Likely benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

CDK12-related disorder Benign:1
Apr 04, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hereditary breast ovarian cancer syndrome Benign:1
Apr 19, 2022
National Health Laboratory Service, Universitas Academic Hospital and University of the Free State
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.022
T;.;T
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.13
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.91
D;D;D
MetaRNN
Benign
0.0024
T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.6
.;L;L
PhyloP100
0.79
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.1
.;N;N
REVEL
Benign
0.080
Sift
Uncertain
0.011
.;D;D
Sift4G
Uncertain
0.039
D;T;T
Polyphen
0.0040, 0.0020
.;B;B
Vest4
0.14, 0.14
MVP
0.41
MPC
0.51
ClinPred
0.017
T
GERP RS
3.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.024
gMVP
0.24
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61741615; hg19: chr17-37682393; COSMIC: COSV70999311; API